Efficacy of Dulaglutide (DU) as First Injectable Option for Patients with Type 2 Diabetes (T2D): A Post Hoc Pooled Analysis

被引：0
|
作者：
Patel, Hiren
Munir, Kashif M.
Sutherland, Sindee S.
Konig, Manige
机构：
来源：
DIABETES | 2019年 / 68卷
关键词：
D O I：
10.2337/db19-2303-PUB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2303-PUB
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Evaluation of First Insulinization by Administration of Basal Insulin in Asian Patients (pts) with Type 2 Diabetes (T2D)
    Tsai, Shih-Tzer
    DIABETES, 2009, 58 : A524 - A524
  • [32] Diabetes Management in Hospitalized Patients with Type 2 Diabetes (T2D) during Fasting Periods
    Rainer, Raphael
    Elsayed, Hesham
    Aberer, Felix
    Beck, Peter
    Pieber, Thomas R.
    Donsa, Klaus
    Plank, Johannes
    Mader, Julia K.
    DIABETES, 2018, 67
  • [33] Evaluation of Characteristics of Gastrointestinal Adverse Events with Once-Weekly Dulaglutide Treatment in Chinese Patients with Type 2 Diabetes: A Post Hoc Pooled Analysis of Two Randomized Trials
    Lixin Guo
    Bin Zhang
    Jianing Hou
    Zhiguang Zhou
    Diabetes Therapy, 2020, 11 : 1821 - 1833
  • [34] Type 2 diabetes (T2D) and quantitative trait association analysis of a Finnish sample with SNPs previously reported to be associated with T2D
    Bonnycastle, LL
    Willer, CJ
    Jackson, AU
    Conneely, KN
    Mohlke, KL
    Scott, LJ
    Narisu, N
    Chines, PS
    Erdos, MR
    Valle, TT
    Buchanan, TA
    Bergman, RN
    Tuomilehto, JA
    Watanabe, RM
    Boehnk, M
    Collins, FS
    DIABETES, 2005, 54 : A43 - A43
  • [35] Evaluation of Characteristics of Gastrointestinal Adverse Events with Once-Weekly Dulaglutide Treatment in Chinese Patients with Type 2 Diabetes: A Post Hoc Pooled Analysis of Two Randomized Trials
    Guo, Lixin
    Zhang, Bin
    Hou, Jianing
    Zhou, Zhiguang
    DIABETES THERAPY, 2020, 11 (08) : 1821 - 1833
  • [36] Type 2 diabetes (T2D) education for adults with ID
    Taggart, L.
    JOURNAL OF APPLIED RESEARCH IN INTELLECTUAL DISABILITIES, 2015, 28 (01) : 58 - 58
  • [37] Dulaglutide decreases liver enzymes in people with type 2 diabetes: a post-hoc analysis of the AWARD programme
    Haupt, A.
    Cusi, K.
    Sattar, N.
    Garcia-Perez, L. -E.
    Pavo, I.
    Yu, M.
    Robertson, K. E.
    DIABETOLOGIA, 2017, 60 : S574 - S575
  • [38] Dulaglutide in Youth with Type 2 Diabetes (T2D) -Results of the AWARD-PEDS Randomized, Placebo-Controlled Trial
    Arslanian, Silva A.
    Cho, Jang Ik
    Hannon, Tamara S.
    Zeitler, Philip
    Chao, Lily
    Barrientos, Margarita
    Boucher-Berry, Claudia C.
    Bismuth, Elise
    Dib, Sergio A.
    Cox, David
    DIABETES, 2022, 71
  • [39] Type 2 Diabetes (T2D) Treatment for Canada's First-Nations Population
    Winterstein, Jeffrey
    Mcgillis, Susan
    DIABETES, 2017, 66 : A461 - A461
  • [40] Effect of Sotagliflozin (SOTA) on Albuminuria in Patients With Type 2 Diabetes (T2D) and CKD
    Cherney, David
    Bhatt, Deepak L.
    Szarek, Michael
    Sun, Franklin W.
    Davies, Michael J.
    Pitt, Bertram
    Steg, Philippe Gabriel
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 675 - 675
12345